循环细胞粘附分子和冠状动脉疾病患者的死亡
S Blankenberg1, H J Rupprecht, C Bickel
1Department of Medicine II, Johannes Gutenberg-University Mainz, Germany. stefan.blankenberg@uni-mainz.de
Circulation
|September 19, 2001
概括
高水平的可溶性粘附分子,包括血管细胞粘附分子-1 (sVCAM-1),预测冠状动脉疾病 (CAD) 患者未来的心血管死亡. 可溶性VCAM-1是致命心血管事件的重要独立预测因子.
科学领域:
- 心血管医学 心血管医学
- 免疫学 免疫学 免疫学
- 生物标志物 生物标志物
背景情况:
- 像VCAM-1,ICAM-1和E-selectin这样的白细胞粘附分子有助于动脉样硬化进展.
- 这些分子调解白细胞粘附和转移,可能导致斑块不稳定.
研究的目的:
- 在冠状动脉疾病 (CAD) 患者中调查可溶性粘附分子和未来心血管事件之间的关联.
- 为了确定可溶性粘附分子是否能比已确定的因素更好地预测风险.
主要方法:
- 对1246名血管学记录的CAD患者进行前性队列研究.
- 基线测量可溶性VCAM-1 (sVCAM-1),sICAM-1和sE-selectin. 的基线测量.
- 对心血管事件的随访时间平均为2.7年.
主要成果:
- 较高的sVCAM-1,sICAM-1和sE-selectin水平与心血管死亡的增加有关.
- 在sVCAM-1的最高四分位数中的患者,死亡事件的风险增加了2.1倍.
- sVCAM-1仍然是心血管死亡的独立预测因素,即使考虑到像hs-CRP这样的炎症标志物.
结论:
- 溶性粘附分子,特别是sVCAM-1,与CAD患者未来的心血管死亡率有显著的联系.
- sVCAM-1增强了传统风险因素和心血管死亡hs-CRP的预测价值.
相关概念视频
Inflammation
Overview
Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


